Join us for lunch and learn about unlocking new views in spatial biology
Hear from researchers at the forefront of translating single-cell spatial data into the clinic as they introduce two novel applications that are redefining personalized approaches to cancer treatment.
Seating is on a first-come, first-serve basis. Due to space restrictions, we may not be able to accommodate everyone. Arrive early to secure your spot.
Spotlight Theater D | Monday, April 8 | 12:30–1:30 pm
Navigating treatments for each cancer patient
Jana Fischer, PhD
Co-Founder and CEO at Navignostics
Navignostics is breaking ground as the first institution to translate spatial insights into the clinic. They are leveraging spatial proteomics into actionable reporting within 72 hours of sample receipt, revolutionizing treatment decisions.
A rapid whole-slide modality to profile the immune landscape
Hartland W. Jackson, PhD
Investigator at the Lunenfeld-Tanenbaum Research Institute and Associate Scientist at the Ontario Institute for Cancer Research
The Lunenfeld-Tanenbaum Research Institute is pioneering rapid whole-slide imaging, scaling multiplexed histopathology measurements with simultaneous detection of immune cells, metabolic states, disease-specific pathways and biomarkers.
Yes, I'd like to join this session.
This Exhibitor Spotlight Theater is a promotional activity and is not approved for continuing education credit. The content of this Exhibitor Spotlight Theater and opinions expressed by presenters are those of the sponsor or presenter and are not of the American Association for Cancer Research®; (AACR).
Unless explicitly and expressly stated otherwise, all products are provided for Research Use Only, not for use in diagnostic procedures. Find more information here.